CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | FENNELL GEORGE SVP, Chief Revenue Officer | Sale | −412 | $575.80 | $237K | 6,712 |
| 2024-02-08 | FENNELL GEORGE SVP, Chief Revenue Officer | Option exercise · Incentive Stock Option (right-to-buy) | −1,612 | 0 | ||
| 2024-02-08 | FENNELL GEORGE SVP, Chief Revenue Officer | Option exercise · Non-Qualified Stock Option (right-to-buy) | −8,198 | 0 | ||
| 2024-02-08 | AYERS JONATHAN W Director | Gift | −850 | 270,744 | ||
| 2024-02-07 | AYERS JONATHAN W Director | Gift | −1,000 | 271,594 | ||
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Option exercise | +23,326 | $141.60 | $3.3M | 53,043.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −615 | $563.82 | $347K | 52,428.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −1,581 | $564.98 | $893K | 50,847.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −701 | $566.53 | $397K | 50,146.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −1,564 | $567.35 | $887K | 48,582.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −1,469 | $568.84 | $836K | 47,113.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −3,912 | $569.91 | $2.2M | 43,201.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −5,675 | $570.97 | $3.2M | 37,526.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −7,128 | $571.84 | $4.1M | 30,398.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Sale | −681 | $572.80 | $390K | 29,717.59 |
| 2024-02-07 | MCKEON BRIAN P EVP, CFO and Treasurer | Option exercise · Non-Qualified Stock Option (right-to-buy) | −23,326 | 0 | ||
| 2024-02-07 | MAZELSKY JONATHAN JAY President and CEO | Option exercise | +12,000 | $67.85 | $814K | 91,246.59 |
| 2024-02-07 | MAZELSKY JONATHAN JAY President and CEO | Sale | −5,356 | $571.71 | $3.1M | 85,890.59 |
| 2024-02-07 | MAZELSKY JONATHAN JAY President and CEO | Sale | −4,124 | $572.53 | $2.4M | 81,766.59 |
| 2024-02-07 | MAZELSKY JONATHAN JAY President and CEO | Sale | −462 | $573.19 | $265K | 81,304.59 |
Page 37 of 52 · 1,036 trades